{
    "2020-08-07": [
        [
            {
                "time": "",
                "original_text": "【浙商医药|周报】持续推荐业绩确定性高CXO板块，关注疫苗板块进展",
                "features": {
                    "keywords": [
                        "CXO板块",
                        "疫苗",
                        "业绩确定性"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "财报解读 | 生物谷：两年“失血”产品单一 为“零人”公司创造上千万收入",
                "features": {
                    "keywords": [
                        "生物谷",
                        "财报",
                        "失血",
                        "产品单一"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药产业发展趋势下，四个投资方向被看好",
                "features": {
                    "keywords": [
                        "医药产业",
                        "投资方向",
                        "趋势"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "如果散户不肯卖出股票，主力会通过这4种骗线对付散户，反复熟记7种“真假突破形态”，别再交出廉价筹码",
                "features": {
                    "keywords": [
                        "散户",
                        "主力",
                        "骗线",
                        "突破形态"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "对话基金经理系列 | 前海联合林材：优选景气行业，精选具备核心竞争力的优质股",
                "features": {
                    "keywords": [
                        "基金经理",
                        "景气行业",
                        "核心竞争力",
                        "优质股"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "健之佳二度冲刺IPO 公司第三大股东引得监管一再“关注”",
                "features": {
                    "keywords": [
                        "健之佳",
                        "IPO",
                        "大股东",
                        "监管关注"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药零售"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}